Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
Healthy Volunteers
NCT05115890

Muscle Blood Flow Regulation in HFpEF

Led by VA Office of Research and Development · Updated on 2026-04-21

35

Participants Needed

1

Research Sites

295 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Heart failure with preserved ejection (HFpEF) disproportionately affects Veterans and is the number one reason for hospital discharge in the VA Health Care System. Exercise intolerance is a common complication experienced by patients with HFpEF, perpetuating physical inactivity and accelerating disease progression. This research proposal aims to elucidate mechanisms responsible for inadequate skeletal muscle blood flow and exercise intolerance in patients with HFpEF compared with healthy controls as well as following 8 weeks of exercise training in patients with HFpEF only.

CONDITIONS

Official Title

Muscle Blood Flow Regulation in HFpEF

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older and able to give written informed consent
  • New York Heart Association (NYHA) functional class II or III
  • Left Ventricular Ejection Fraction (LVEF) > 50%
  • Plasma Brain Natriuretic Peptide (BNP) >200 pg/mL or NT-proBNP 400 pg/mL at enrollment
Not Eligible

You will not qualify if you...

  • Prior ejection fraction less than 50%
  • NYHA Class IV or heart failure that cannot be stabilized on optimized pharmacotherapy
  • Acute coronary syndrome, infiltrative cardiomyopathy, or myocarditis
  • HFpEF caused by significant uncorrected primary valvular disease (except mitral regurgitation due to left ventricular dysfunction)
  • Orthopedic problems preventing knee-extensor exercise
  • Women currently using hormone replacement therapy
  • Women who are pregnant or may become pregnant
  • Current smokers

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

VA Salt Lake City Health Care System, Salt Lake City, UT

Salt Lake City, Utah, United States, 84148-0001

Actively Recruiting

Loading map...

Research Team

K

Kanokwan Bunsawat, PhD

CONTACT

D

David W Wray, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here